drugset / Trial / NCT00704912

Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women

NCT00704912

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this three-armed randomized controlled trial is to establish the relative roles of treatment of hyperandrogenism versus obesity (as the largest modifiable factor contributing to insulin resistance) in treating infertility and improving pregnancy outcomes among obese PCOS women. The investigators hypothesize that the key to restoring ovulation leading to live birth is to correct hyperandrogenism with oral contraceptive pills, but the key to avoiding later pregnancy complications is to improve insulin sensitivity with weight loss.

Timeline

Start
2008-09
Primary completion
2014-03
Completion
2014-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Loestrin 1/20 Unknown Oral
Comparator Orlistat Small molecule 60 mg